James Abe will speak on the panel “Biotech IP Protection in the US” at the Bay Area CHIZAI 43rd Seminar.
Intellectual property is a key resource for biotech companies, and its protection is central to their future success. Pharmaceutical and biotech companies are tackling challenges of creating value through the utilization of IP rights.
In this seminar, James joins a variety of prominent IP experts in the biotech field discuss how companies’ in-house counsels are realizing IP protection/utilization through cooperation with outside counsels from various perspectives. The panel will also explain the hottest patent law issues in this area including written description/enablement requirements and give some advice on patent prosecution and litigation strategies.
For more information, click here.